Impact of pharmacy closures and structural racism on medication adherence in older adults

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries

NIH-funded research University of Southern California · NIH-11080994

This study looks at how things like racism and the closing of pharmacies make it harder for older Black and Hispanic adults on Medicare to get their medications, helping us understand the challenges they face in staying healthy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern California NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project IDNIH-11080994 on NIH RePORTER

What this research studies

This research investigates how structural racism and pharmacy closures affect medication adherence among older adult Medicare Part-D beneficiaries, particularly focusing on racial and ethnic disparities. It aims to understand the community-level barriers that older Black and Hispanic individuals face in accessing their medications, which are often exacerbated by geographic segregation and pharmacy accessibility issues. By analyzing various data sources, the research will explore the relationship between pharmacy closures and medication adherence rates, highlighting the role of Medicare Part-D policies in these disparities.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adult Medicare Part-D beneficiaries, especially those from Black and Hispanic backgrounds living in areas affected by pharmacy closures.

Not a fit: Patients who are younger than 65 or those who do not rely on Medicare Part-D for their medications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved policies that enhance medication access and adherence for older adults, particularly in minority communities.

How similar studies have performed: While the specific focus on pharmacy closures and structural racism is relatively novel, previous research has shown that addressing community-level barriers can significantly improve health outcomes for marginalized populations.

Where this research is happening

Los Angeles, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.